Search results
Pfizer's first-quarter results top estimates, while drugmaker boosts full-year profit outlook
Morningstar· 2 days agoPfizer Inc. on Wednesday reported first-quarter profit and sales that beat analyst expectations and raised its full-year earnings guidance as cancer and heart-disease drugs ...
US FDA approves Pfizer's gene therapy for rare bleeding disorder
Reuters· 6 days ago, opens new tab gene therapy for hemophilia B on Friday, the second such therapy for the rare...
FTC targets ‘junk patents’ on Ozempic, other top drugs
BioPharma Dive via Yahoo Finance· 2 days agoThe move broadens the antitrust regulator’s campaign against allegedly “improper or inaccurate”...
Pfizer Gets FDA OK For Beqvez Gene Therapy for Hemophilia B
Morningstar· 7 days agoPfizer has won Food and Drug Administration approval of Beqvez, a one-time gene therapy for certain patients with ...
Moderna expects CDC to view its RSV vaccine as equal to rival shots
Reuters· 12 hours ago, opens new tab said on Thursday it expects U.S. Center for Disease Control and Prevention (CDC)...
Moderna COVID vaccine sales plummet 91 percent - The Boston Globe
The Boston Globe· 11 hours agoShares of Moderna rose more than 7 percent in early morning trading. Pfizer, the New York-based drug...
Is Moderna Stock A Buy On Its Eye-Popping First-Quarter Sales Beat?
Investor's Business Daily· 10 hours agoAfter a year of treatment, most patients had none or a lower rate of metabolic decompensation...
Moderna’s sales from its only product, the COVID-19 vaccine, fell 91% from last year
Fortune via Yahoo Finance· 5 hours agoThe company’s RSV vaccine entered the third of five clinical research phases the Food and Drug ...
Pfizer Gets FDA OK For Beqvez Gene Therapy for Hemophilia B
Market Watch· 7 days agoPfizer has won Food and Drug Administration approval of Beqvez, a one-time gene therapy for certain patients with ...
Should You Buy Moderna Before May 12?
Motley Fool via Yahoo Finance· 7 days agoThe U.S. Food and Drug Administration (FDA) is set to issue a decision on the company's respiratory syncytial virus (RSV) vaccine candidate ...
